Peter Attia· MD
about 27 of them if we extracted this correctly off clinicaltrials.gov are in phase one so for the listener meaning these are drugs that are really just being evaluated for safety at this point
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
about 27 of them if we extracted this correctly off clinicaltrials.gov are in phase one so for the listener meaning these are drugs that are really just being evaluated for safety at this point
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
about 65 are in phase two so that means they've passed that bar of being safe or at least safe enough to proceed to phase two where now we're looking for some efficacy and we'll of course continue to monitor safety